Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists

Samuele Stazzoni,Daniel F.R. Böhmer,Fabian Hernichel,Dilara Özdemir,Aikaterini Pappa,David Drexler,Stefan Bauernfried,Gregor Witte,Mirko Wagner,Simon Veth,Karl-Peter Hopfner,Veit Hornung,Lars M. König,Thomas Carell
DOI: https://doi.org/10.1002/anie.202207175
2022-07-26
Angewandte Chemie International Edition
Abstract:cGAMP is a cyclic A‐ and G‐containing dinucleotide second messenger, which is formed upon cellular recognition of foreign cytosolic DNA as part of the innate immune response. The molecule binds to the adaptor protein STING, which induces an immune response characterized by the production of type I interferon and cytokines. The development of STING‐binding molecules with both agonistic as well as antagonistic properties is currently of tremendous interest to induce or enhance antitumour or antiviral immunity on the one hand, or to treat autoimmune diseases on the other hand. To escape the host innate immune recognition, some viruses encode poxin endonucleases that cleave cGAMP. Here we report that dideoxy‐2',3'‐cGAMP ( 1 ) and analogs thereof, which lack the secondary OH‐ribose groups, form a group of poxin‐stable STING agonists. Despite their reduced affinity to STING, particularly the compound constructed from two A nucleosides, dideoxy‐2',3'‐cAAMP ( 2 ), features an unusually high antitumour response in mice.
What problem does this paper attempt to address?